Plasma levels of 9-deoxo-16,15-dimethyl-9-methylene-PGE2 in connection with its development as an abortifacient
- 1 October 1982
- journal article
- research article
- Published by Elsevier in Prostaglandins
- Vol. 24 (4) , 451-466
- https://doi.org/10.1016/0090-6980(82)90003-x
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Self-administration of prostaglandin for termination of early pregnancyContraception, 1981
- A comparison of two stable prostaglandin E analogues for termination of early pregnancy and for cervical dilatationContraception, 1980
- Quantitative determination of 9-deoxo-16,16-dimethyl-9-methylene-PGE2 in human plasma by GC-MS, RIA and HPLCProstaglandins, 1980
- Mid-trimester abortion by vaginal administration of 9-deoxo-16, 16-dimethyl-9-methylene-PGE2Contraception, 1980
- NEW PROSTAGLANDIN E2 ANALOGUE FOR PREGNANCY TERMINATIONThe Lancet, 1979
- Synthesis and biological properties of 9-deoxo-16,16-dimethyl-9-methylene-PGE2Prostaglandins, 1979
- Plasma levels of 15(S) 15-methyl PGF2α following administration via various routes for induction of abortionProstaglandins, 1977